Tecom embarks on its next phase of growth
Burjeel Holdings, a trailblazer in healthcare services, was awarded the prestigious title of “Middle East’s Leader in Healthcare Excellence” during the i3 Summit’s “Recognitions” segment.
Burjeel Holdings has consistently redefined healthcare, starting with a single hospital in Abu Dhabi in 2007. Dr Shamsheer Vayalil, its founder and chairman, envisioned quality healthcare for all. Today, their journey is marked by cutting-edge technology and world-renowned medical talent, epitomised by the flagship Burjeel Medical City.
In October 2022, Burjeel Holdings made history by becoming the largest healthcare provider listed on the Abu Dhabi Securities Exchange. Within a year, they achieved double-digit profit and patient footfall growth, rewarding shareholders with a debut dividend.
With 16 hospitals and 24 medical centers spanning the UAE and Oman, Burjeel Holdings champions innovative treatments, collaborating with global experts in oncology, nuclear medicine, orthopedics, women’s care, and more.
Burjeel Holdings’ unique hub-and-spoke healthcare model brings top-notch private hospitals closer to communities, setting a benchmark with cutting-edge technologies and innovative practices.
Khaleej Times proudly announces Burjeel Holdings as the “Middle East’s Leader in Healthcare Excellence” at i3 Summit, a testament to their unwavering commitment to revolutionize healthcare. The award was received by Mr. John Sunil, chief executive officer of burjeel holdings and Mr. Muhammed Shihabuddin, chief finance officer of Burjeel Holdings.
Tecom embarks on its next phase of growth
Loyalty schemes, AI and customer retention will be key
Transaction value expected to hit $29.75 billion this year
Overall volume of digital payments in Mena has grown nearly seven-fold since 2020
In 2023, total consumption of gold in the UAE reached 39.7 tonnes
Maritime India Vision 2030 envisions investment of Rs1.25 trillion
Profitability, cash flow and capital expenditure guidance reiterated
Swiss pharma firm has an annual capacity of 250 million tablets